good news , page-13

I just think we are all tired. Plus I find the refrain of "has always had positive ANN's" as a little grating.

It is deeply disturbing they have not
A) Updated on the status/progress of things when they have passed the timelines by significant amounts as to when results were expected and provide no market ANN as to the delay.

B) Their announcement ANN's are always good but they continue to skirt the major concern. Its a major elephant in the room.

Now I know trials never go according to plan but the fact they don't clear things up with the market is bizzare.

I recall one member on this forum being sent an email explaining the reason for the delay was because of the partnership with Teva I think or something along those lines.

How is it they can email that but they say not a word to the market? Bizarre behavior.
Doesn't build trust in my opinion.